07:47 AM EDT, 08/06/2025 (MT Newswires) -- Charles River Laboratories ( CRL ) reported fiscal Q2 non-GAAP earnings Wednesday of $3.12 per diluted share, up from $2.80 a year earlier.

Analysts surveyed by FactSet expected $2.50.

Revenue for the quarter ended June 28 was $1.032 billion, up from $1.026 billion a year earlier.

Analysts surveyed by FactSet expected $985.2 million.

The company said it now expects fiscal 2025 non-GAAP EPS of between $9.90 and $10.30, up from the earlier projection of $9.30 to $9.80. Analysts surveyed by FactSet expect $9.65. Revenue for the full year is now expected to decline 2.5% to 0.5%, an improvement from the prior outlook of a decline of 5.5% to 3.5%. Analysts polled by FactSet are looking for $3.90 billion.

Charles River Laboratories ( CRL ) shares were up more than 4% in recent premarket activity Wednesday.